Activation of Th17/Th1 and Th1, but not Th17, is associated with the acute cardiac event in patients with acute coronary syndrome

Atherosclerosis

Volumn 217, Issue 2, 2011, Pages 518-524

  Zhao, Zhao ^a,b   Wu, Yue ^a   Cheng, Manli ^b   Ji, Yuqiang ^b   Yang, Xiaobo ^a   Liu, Ping ^a   Jia, Shaobin ^a,c   Yuan, Zuyi ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b First Hosp of Xi'an Jiaotong Univ   (China)

^c AFFILIATED HOSPITAL OF NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Acute coronary syndrome; Atherosclerosis; Regulatory T cells; Th17; Th17 Th1

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 17; RETINOID RELATED ORPHAN RECEPTOR GAMMA; STAT3 PROTEIN; STAT4 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL POPULATION; CONTROLLED STUDY; CORONARY ARTERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL;

ACUTE CORONARY SYNDROME; AGED; ANGINA, UNSTABLE; CASE-CONTROL STUDIES; CELLS, CULTURED; CHINA; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REAL-TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTORS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS; TH2 CELLS;

EID: 79960700561     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.03.043     Document Type: Article

References (29)

1. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
2. Methe H., Brunner S., Wiegand D., et al. Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes. J Am Coll Cardiol 2005, 45:1939-1945.
3. Mor A., Luboshits G., Planer D., et al. Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Eur Heart J 2006, 27:2530-2537.
4. Laurat E., Poirier B., Tupin E., et al. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation 2001, 104:197-202.
5. Koga M., Kai H., Yasukawa H., et al. Inhibition of progression and stabilization of plaques by postnatal interferon-gamma function blocking in apoE-knockout mice. Circ Res 2007, 101:348-356.
6. Whitman S.C., Ravisankar P., Daugherty A. IFN-γ deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice. J Interferon Cytokine Res 2004, 22:661-670.
7. Buono C., Binder C.J., Stavrakis G., et al. T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. Proc Natl Acad Sci U S A 2005, 102:1596-1601.
8. King V.L., Cassis L.A., Daugherty A. Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice. Am J Pathol 2007, 171:2040-2047.
9. Mallat Z., Gojova A., Brun V., et al. Induction of a regulatory T cell Type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 2003, 108:1232-1237.
10. Smith E., Prasad K.M., Butcher M., et al. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 2010, 121:1746-1755.
11. Erbel C., Chen L., Bea F., et al. Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice. J Immunol 2009, 183:8167-8175.
12. Taleb S., Romain M., Ramkhelawon B., et al. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J Exp Med 2009, 206:2067-2077.
13. Li Q., Wang Y., Chen K., et al. The role of oxidized low-density lipoprotein in breaking peripheral Th17/Treg balance in patients with acute coronary syndrome. Biochem Biophys Res Commun 2010, 394:836-842.
14. Cheng X., Yu X., Ding Y.J., et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008, 127:89-97.
15. Eid R.E., Rao D.A., Zhou J., et al. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009, 119:1424-1432.
16. Annunziato F., Cosmi L., Santarlasci V., et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007, 204:1849-1861.
17. Bending D., De La Pena H., et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest 2009, 119:565-572.
18. Bogaty P., Brecker S.J., White S.E., et al. Comparison of coronary angiographic findings in acute and chronic first presentation of ischemic heart disease. Circulation 1993, 87:1938-1946.
19. De Palma R., Del Galdo F., Abbate G., et al. Patients with acute coronary syndrome show oligoclonal T-cell recruitment within unstable plaque: evidence for a local, intracoronary immunologic mechanism. Circulation 2006, 113:640-646.
20. WuY, Zhang W., Liu W., et al. The double-faced metabolic andinflammatory effects of standard drug therapy in patients after percutaneous treatment with drug-eluting stent. Atherosclerosis 2011, 215:170-175.
21. van der Wal A.C, Becker A.E., van der Loos C.M., et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994, 89:36-44.
22. Sasaki N., Yamashita T., Takeda M., et al. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice. Circulation 2009, 120:1996-2005.
23. Hansson G.K., Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006, 6:508-519.
24. Ranjbaran H., Sokol S.I., Gallo A., et al. An inflammatory pathway of IFN-gamma production in coronary atherosclerosis. J Immunol 2007, 178:592-604.
25. Elhage R., Jawien J., Rudling M., et al. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res 2003, 59:234-240.
26. Ji Y., Zhang W. Th17 cells: positive or negative role in tumor?. Cancer Immunol Immunother 2010, 59(7):979-987.
27. Pejnovic N., Vratimos A., Lee S.H., et al. Increased atherosclerotic lesions and Th17 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet. Mol Immunol 2009, 47:37-45.
28. Fernandes J.L., Mamoni R.L., Orford J.L., et al. Increased Th1 activity in patients with coronary artery disease. Cytokine 2004, 26:131-137.
29. Annunziato F., Romagnani S. Do studies in humans better depict Th17 cells?. Blood 2009, 114:2213-2219. 10.